Acquired by OrthoPediatrics MD Orthopaedics was acquired by OrthoPediatrics Corp. in early 2022 for 8.2 million, indicating integration into a pediatric-focused orthopedic portfolio. This creates potential cross-sell opportunities with OrthoPediatrics’ existing customer base and distribution channels.

Clubfoot Leadership The company pioneered a clubfoot brace and maintains ongoing innovation around the Mitchell Ponseti Ankle-Foot Orthosis system. This positions MD Orthopaedics as a specialist with premium, evidence-backed products that can be bundled with related pediatric orthotics to expand product offerings.

Small, Focused Team With 11-50 employees, the organization operates as a lean specialist supplier. Sales opportunities may be optimized by targeted outreach, leveraging concise product education, and rapid onboarding support for hospital purchasing teams.

Revenue Range Current revenue is in the $1M–$10M range, suggesting room for revenue growth through expanded hospital contracts, distributor partnerships, and international distribution where pediatric orthotics demand is strong.

Strategic Fit for Partners Similar companies in the medtech space with larger teams and established distributions (e.g., Ottobock, DeRoyal) indicate a competitive market where partnerships, OEM agreements, and co-branding with pediatric-focused players could accelerate market penetration for MD Orthopaedics’ AFO systems.